WASHINGTON (CN) - Some Hospira Carpuject pre-filled syringe cartridges contain extra medication, which may produce an overdose, according to a Food and Drug Administration press release. Pharmacies ...

May 23, 2012 — The US Food and Drug Administration (FDA) today issued an advisory warning healthcare providers to visually inspect Hospira Carpuject prefilled cartridges for overfill. About 46 million ...

UNDATED - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

April 19, 2012 — Hospira Inc has initiated a voluntary recall of morphine sulfate injections because of a customer report of 2 Carpuject syringes containing more than the 1 mL labeled fill volume. The ...

One lot of hydromorphone HCI injection 1 mg/mL manufactured by Hospira (Dilaudid) is being recalled due to reports that the prefilled glass cartridges designed for use in the Carpuject Syringe system ...

Pfizer notified customers Jan. 31 it is having difficulty making certain prefilled syringes of opioid painkillers — marking the third time in six months the company has encountered manufacturing ...

Hospira announced a nationwide voluntary recall of one lot of Morphine Sulfate injection, 4mg/mL, due to a customer report of two Carpujects syringes containing more than the 1mL labeled fill volume.